secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAMBELL INTERNATIONAL HOLDING CORP. (—)
CIK:        0001678848
Form:       8-K
Filed at:   2022-12-30T23:59:59+00:00
Accession:  0001213900-22-084079
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 2.01, 3.02, 5.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bitmis completes reverse merger with Cambell International, shifts focus to β-carotene health products
--------------------------------------------------------------------------------

- Reverse acquisition of Cambell International closed on Dec 30, 2022; Bitmis issued 1M common shares and transferred 9M Series A Preferred shares to Cambell shareholders.
- Xiaoyan Yuan resigned as CEO/CFO/COO/director; Sun Xiuzhi appointed as CEO, CFO, and director effective immediately.
- Post-merger, company will focus on natural β-carotene extraction and health food products via LiaoNing KangBaiEr Biotechnology Development Co., Ltd.
- Bitmis trades on OTC Expert Market under ticker BIMT; no financial statements provided yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1678848/000121390022084079/0001213900-22-084079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1678848/000121390022084079/ea171076-8k_bitmiscorp.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-084079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer